Abstract:
A water treatment system (1) comprising a primary gastight treatment chamber (21) comprising: a closable water inlet (26), and a water outlet (29) closed by a membrane (5), wherein the membrane prevents a flow of water when the pressure in the chamber is below a predetermined threshold and allowing the flow of water therethrough and out of the chamber when the pressure in the chamber is above the predetermined threshold, and micromotors (3) inside the treatment chamber, wherein the micromotors comprise: a functional region (32) comprising a material functionalized to remove a pollutant (34) from the water, and a driving region (31) comprising a material for generating gas bubbles (33) and causing build-up of pressure inside the chamber. A water treatment method is also provided.
Abstract:
The present invention provides a hydrogel capsule comprising a cell, a protein, and a cross-linking agent; wherein the cell is within a first core layer comprising the protein; and wherein the first core layer is surrounded by a second layer comprising the protein and the cross-linking agent. The invention further provides the hydrogel capsule for use in therapy, prognosis and diagnosis, a method for culturing cells, a method for differentiating cells, and method for producing the hydrogel capsule. The hydrogel capsules of the invention are particularly useful for encapsulating pancreatic islets.
Abstract:
The disclosure relates to a system and a method of analysing a physiological condition in an analyte. In particular, the disclosure pertains to systems, components of such systems, and methods of analysing a physiological condition in an analyte using hyperpolarization (HP) and magnetic resonance (MR) techniques.
Abstract:
An electrochemical sensor system for sensing analytical reactions and biological operations is provided. The electrochemical sensor system comprises: an amperometric sensor comprising two electrodes, wherein the electrodes comprise a working electrode and a reference electrode, wherein the amperometric sensor includes no other electrodes and a potentiometric sensor comprising a working electrode and a reference electrode, wherein the potentiometric sensor includes no other electrodes, wherein the reference electrode of the potentiometric sensor is coupled to ground, wherein the working electrode of the amperometric sensor is electrically coupled to the reference electrode of the potentiometric sensor, wherein the amperometric sensor is configured to receive an excitation voltage between the working electrode of the amperometric sensor and the reference electrode of the amperometric sensor such that the received excitation voltage is used as a reference voltage of the potentiometric sensor via the reference electrode of the potentiometric sensor.
Abstract:
A method for obtaining one or more free-form individual fibers of biocompatible hydrogels with a predefined diameter, wherein said method comprises the use of a printing system comprising at least a first nozzle (110) and a second nozzle (120) surrounding the first nozzle, wherein said method comprises the following steps: a) providing a printable biocompatible hydrogel (130) in the first nozzle; b) providing a printable composition (140) comprising a non-toxic thermoreversible gelation polymer in the second nozzle; c) extruding the biocompatible hydrogel in a) and the composition in b) simultaneously through the nozzles, wherein the composition in b) in a gel state coats the extruded biocompatible hydrogel; d) optionally, submitting the obtained one or more individual fibers to a cross- linking treatment; e) optionally, removing the composition in b) from the external surface of the deposited one or more fibers.
Abstract:
Inhibitors of talin-vinculin binding for the treatment of cancer The present invention provides a compound inhibiting the interaction between talin and vinculin for use in the treatment of a solid tumor.
Abstract:
Bis(aminostyrylpyridinium) compounds of formula (I) and pharmaceutical acceptable salts thereof are provided for use as a medicament. Additionally, multiple novel bis(aminostyrylpyridinium) compounds of formula (I) are provided. The present invention relates to compounds of formula (I) and compositions for use in the treatment of a disease whose etiology is based on protein aggregation. Particularly, compounds are useful in the treatment, prevention or amelioration of malaria, or symptoms, complications and/or sequelae thereof.
Abstract:
La presente invención es un dron para la medición de concentración de olor caracterizado por una configuración específica que permite la toma de muestras en localizaciones que de otra forma tendrían difícil acceso o no serían accesibles y, en unas condiciones en las que los medios de impulsión no afectan a la medida. Adicionalmente, la invención está caracterizada por el correcto marcado de la localización espacial de cada toma de muestra y medida aunque la toma de muestra y medida requiera un tiempo de transporte del aire aspirado.
Abstract:
Microfluidic structure (1) for carrying out biological assays, which comprises a first assay channel (C1) and a second assay channel (C2) coplanar, identical and arranged in parallel, a first inlet port (I1) for inserting a first fluid, a second inlet port (I2) for inserting a second fluid, a common outlet (O1), and a distributing channel system (D) comprising a common connection point or pre-chamber (V), a first supply channel (IP1) connecting the first inlet port (I1) with the common connection point (V), a second supply channel (IP2) connecting the second inlet port (I2) with the common connection point (V), a first distribution channel (PC1) connecting the common connection point (V) with the first assay channel (C1), a second distribution channel (PC2) separate from the first distribution channel (PC1) connecting the common connection point (V) with the second assay channel (C2), and a first outlet channel (CO1) connecting the first assay channel (C1) with the common outlet (O1) and a second outlet channel (CO2) separate from the first outlet channel (CO1) connecting the second assay channel (C2) with the common outlet (O1). The invention also relates to a chip (2) having two or more of such microfluidic structures (1) and a method wherein such microfluidic structure is used.
Abstract:
The present invention relates a compound of formula (I) in Z-isomer form (Z-(l)) or a compound of formula (I) in E-isomer form (E-(l)) wherein: R 2 is a radical of formula (II) and of formula (III); X 1 , X 2 , X 3 , X 4 and X 5 are CR 3 and N; Y 1 is NH, O and S; each R 1 , each R 3 and R 7 are H, halogen, -OH, -O-(C 1 -C 8 )alkyl, -N((C 1 -C 8 )alkyl) 3 , -NH((C 1 -C 8 )alkyl) 2 , and -NH 2 (C 1 -C 8 )alkyl; R 4 , R 5 and R 6 are H and (C 1 -C 8 )alkyl; - - - line indicates the position of R 2 radical by which R 2 is attached to the adjacent N; and the asterisk indicates a stereogenic carbon atom being in R -isomer, S -isomer and a mixture of R -isomer and S -isomer. It also relates to the compound Z-(l) for use as a medicament; and the compound E-(l) for use in the treatment of a disease or condition mediated by the dihydrofolate reductase, wherein the treatment comprises exposing a compound E-(I) to light irradiation to obtain the compound Z-(l).